414 related articles for article (PubMed ID: 17098031)
1. Early recurrence of nephrotic syndrome (immunoglobulin m nephropathy) after renal transplantation successfully treated with combinations of plasma exchanges, immunoglobulin, and rituximab.
Westphal S; Hansson S; Mjörnstedt L; Mölne J; Swerkersson S; Friman S
Transplant Proc; 2006 Oct; 38(8):2659-60. PubMed ID: 17098031
[TBL] [Abstract][Full Text] [Related]
2. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis.
Gossmann J; Scheuermann EH; Porubsky S; Kachel HG; Geiger H; Hauser IA
Transpl Int; 2007 Jun; 20(6):558-62. PubMed ID: 17433091
[TBL] [Abstract][Full Text] [Related]
3. [Efficiency of rituximab treatment for recurrence of membranous glomerulopathy after renal transplantation].
Wéclawiak H; Ribes D; Modesto A; Kamar N; Durand D; Rostaing L
Nephrol Ther; 2007 Apr; 3(2):65-8. PubMed ID: 17452303
[TBL] [Abstract][Full Text] [Related]
4. Recurrent nephrotic syndrome after living-related renal transplantation resistant to plasma exchange: report of two cases.
Masutani K; Katafuchi R; Ikeda H; Yamamoto H; Motoyama K; Sugitani A; Kanai H; Kumagai H; Hirakata H; Tanaka M; Iida M
Clin Transplant; 2005; 19 Suppl 14():59-64. PubMed ID: 15955171
[TBL] [Abstract][Full Text] [Related]
5. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: case reports.
Fencl F; Simková E; Vondrák K; Janda J; Chadimová M; Stejskal J; Seeman T
Transplant Proc; 2007 Dec; 39(10):3488-90. PubMed ID: 18089416
[TBL] [Abstract][Full Text] [Related]
6. Anti-CD20 monoclonal antibody (rituximab) for the treatment of membranous nephropathy after living-unrelated kidney transplantation: a case report.
Sirimongkolrat T; Premasathian N; Vongwiwatana A; Limsrichamrern S; Cheunsuchon B; Vasuvattakul S
Transplant Proc; 2008 Sep; 40(7):2440-1. PubMed ID: 18790261
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab.
Hristea D; Hadaya K; Marangon N; Buhler L; Villard J; Morel P; Martin PY
Transpl Int; 2007 Jan; 20(1):102-5. PubMed ID: 17181660
[TBL] [Abstract][Full Text] [Related]
8. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
Rodríguez-Ferrero M; Ampuero J; Anaya F
Transplant Proc; 2009; 41(6):2406-8. PubMed ID: 19715934
[TBL] [Abstract][Full Text] [Related]
9. Complete reversal of the nephrotic syndrome after preemptive pancreas-kidney transplantation: a case report.
Piccoli GB; Rossetti M; Marchetti P; Grassi G; Picciotto G; Barsotti M; Vistoli F; Burdese M; Sargiotto A; Mezza E; Soragna G; Bermond F; Gai M; Motta D; Lanfranco G; Dani F; Jeantet A; Boggi U; Segoloni GP
Transplant Proc; 2004 Apr; 36(3):589-90. PubMed ID: 15110603
[TBL] [Abstract][Full Text] [Related]
10. Rituximab for post-transplant recurrences of FSGS.
Bayrakci US; Baskin E; Sakalli H; Karakayali H; Haberal M
Pediatr Transplant; 2009 Mar; 13(2):240-3. PubMed ID: 18822107
[TBL] [Abstract][Full Text] [Related]
11. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome.
Dantal J; Bigot E; Bogers W; Testa A; Kriaa F; Jacques Y; Hurault de Ligny B; Niaudet P; Charpentier B; Soulillou JP
N Engl J Med; 1994 Jan; 330(1):7-14. PubMed ID: 8259160
[TBL] [Abstract][Full Text] [Related]
12. Protocol biopsies for focal segmental glomerulosclerosis treated with plasma exchange and rituximab in a renal transplant patient.
Sakai K; Takasu J; Nihei H; Yonekura T; Aoki Y; Kawamura T; Mizuiri S; Aikawa A
Clin Transplant; 2010 Jul; 24 Suppl 22():60-5. PubMed ID: 20590697
[TBL] [Abstract][Full Text] [Related]
13. Effects of plasma-protein A immunoadsorption on idiopathic nephrotic syndrome recurring after renal transplantation.
Dantal J; Testa A; Bigot E; Soulillou JP
Ann Med Interne (Paris); 1992; 143 Suppl 1():48-51. PubMed ID: 1300888
[TBL] [Abstract][Full Text] [Related]
14. A case of recurrent immunotactoid glomerulopathy in an allograft treated with rituximab.
Sathyan S; Khan FN; Ranga KV
Transplant Proc; 2009 Nov; 41(9):3953-5. PubMed ID: 19917422
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
Busch M; Gerth J; Ott U; Schip A; Haufe CC; Gröne HJ; Wolf G
Med Klin (Munich); 2008 Jul; 103(7):519-24. PubMed ID: 18604487
[TBL] [Abstract][Full Text] [Related]
16. [Long-term monitoring of children with focal segmental glomerulosclerosis and a transplanted kidney].
Seso Simić D; Slavicek J; Bubić Filipi L; Puretić Z; Kes P
Acta Med Croatica; 2003; 57(1):53-6. PubMed ID: 12876864
[TBL] [Abstract][Full Text] [Related]
17. Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children.
Salomon R; Gagnadoux MF; Niaudet P
Transplantation; 2003 Mar; 75(6):810-4. PubMed ID: 12660507
[TBL] [Abstract][Full Text] [Related]
18. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
Peters HP; van de Kar NC; Wetzels JF
Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266
[TBL] [Abstract][Full Text] [Related]
19. Resolution of IgM nephropathy after rituximab treatment.
Betjes MG; Roodnat JI
Am J Kidney Dis; 2009 Jun; 53(6):1059-62. PubMed ID: 19084309
[TBL] [Abstract][Full Text] [Related]
20. Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis.
Meyer TN; Thaiss F; Stahl RA
Transpl Int; 2007 Dec; 20(12):1066-71. PubMed ID: 17887957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
